Indications
Fampyra is indicated for the improvement of walking in adult patients with multiple sclerosis with walking disability (Expanded Disability Status Scale 4-7).
Composition
- Active substance
- Fampridine
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Fampyra
- Active substance
- Fampridine
- ATC code
- N07XX07
- Group
- Nervous system
- Therapeutic area
- Multiple Sclerosis
- Marketing authorisation holder
- Merz Therapeutics GmbH
- Status
- Authorised
- EU authorisation
- 20 Jul 2011